Optoceutics ApS

Optoceutics ApS is an SME in Kobenhavn V, Denmark that has taken part in 2 EU-funded projects since 2019, receiving €645k in EU funding and leading 1 as coordinator.

EU funding received€645k
EU projects2
As coordinator1
Running now0
First EU project2019
Latest project2020
CountryDenmark
EU registration (PIC)900972473
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Optoceutics ApS's own share of each project, not the project's full budget.

  • Horizon 2020€645k · 2 projects

Projects

2 EU-funded projects, newest first. Optoceutics ApS led 1 of them as coordinator. Each links to the official record.

  • ASTROTECHPartner

    Disruptive materials, technologies & approaches to unravel the role of Astrocytes in brain function and dysfunction: towards to Glial interfaces

    Horizon 2020 · 2020–2025 · Project on CORDIS ↗

    €595ktheir share
  • BRIGHTCoordinator

    40 Hz Masked Light: A new venture to slow the progression of Alzheimer’s Disease

    Horizon 2020 · 2019–2019 · Project on CORDIS ↗

    €50ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • alzheimer
  • biomaterials
  • biosensing
  • business models
  • colors
  • epilepsy
  • neurobiology
  • physiology
  • public health

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime